Literature DB >> 16611920

Linkage of reduced receptor affinity and superinfection to pathogenesis of TR1.3 murine leukemia virus.

Samuel L Murphy1, Maeran Chung-Landers, Marek Honczarenko, Glen N Gaulton.   

Abstract

TR1.3 is a Friend murine leukemia virus (MLV) that induces selective syncytium induction (SI) of brain capillary endothelial cells (BCEC), intracerebral hemorrhage, and death. Syncytium induction by TR1.3 has been mapped to a single tryptophan-to-glycine conversion at position 102 of the envelope glycoprotein (Env102). The mechanism of SI by TR1.3 was examined here in comparison to the non-syncytium-inducing, nonpathogenic MLV FB29, which displays an identical BCEC tropism. Envelope protein expression and stability on both infected cells and viral particles were not statistically different for TR1.3 and FB29. However, affinity measurements derived using purified envelope receptor binding domain (RBD) revealed a reduction of >1 log in the K(D) of TR1.3 RBD relative to FB29 RBD. Whole-virus particles pseudotyped with TR1.3 Env similarly displayed a markedly reduced binding avidity compared to FB29-pseudotyped viral particles. Lastly, decreased receptor affinity of TR1.3 Env correlated with the failure to block superinfection following acute and chronic infection by TR1.3. These results definitively show that acquisition of a SI phenotype can be directly linked to amino acid changes in retroviral Env that decrease receptor affinity, thereby emphasizing the importance of events downstream of receptor binding in the cell fusion process and pathology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16611920      PMCID: PMC1472024          DOI: 10.1128/JVI.80.9.4601-4609.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Induction of syncytia by neuropathogenic murine leukemia viruses depends on receptor density, host cell determinants, and the intrinsic fusion potential of envelope protein.

Authors:  M Chung; K Kizhatil; L M Albritton; G N Gaulton
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Identification of a receptor-binding pocket on the envelope protein of friend murine leukemia virus.

Authors:  R A Davey; Y Zuo; J M Cunningham
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

3.  Syncytium formation induced by human immunodeficiency virus type 1 isolates correlates with affinity for CD4.

Authors:  B A Watkins; R Crowley; A E Davis; A T Louie; M S Reitz
Journal:  J Gen Virol       Date:  1997-10       Impact factor: 3.891

4.  Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution.

Authors:  D Fass; R A Davey; C A Hamson; P S Kim; J M Cunningham; J M Berger
Journal:  Science       Date:  1997-09-12       Impact factor: 47.728

5.  Activation of a beta-galactosidase recombinant provirus: application to titration of human immunodeficiency virus (HIV) and HIV-infected cells.

Authors:  D Rocancourt; C Bonnerot; H Jouin; M Emerman; J F Nicolas
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

6.  Biological, molecular, and structural analysis of a cytopathic variant from a molecularly cloned simian immunodeficiency virus.

Authors:  C C LaBranche; M M Sauter; B S Haggarty; P J Vance; J Romano; T K Hart; P J Bugelski; J A Hoxie
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  A point mutation in the env gene of a murine leukemia virus induces syncytium formation and neurologic disease.

Authors:  B H Park; B Matuschke; E Lavi; G N Gaulton
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Role of N-linked glycosylation in the activity of the Friend murine leukemia virus SU protein receptor-binding domain.

Authors:  J L Battini; S C Kayman; A Pinter; J M Heard; O Danos
Journal:  Virology       Date:  1994-07       Impact factor: 3.616

9.  Relationship between SU subdomains that regulate the receptor-mediated transition from the native (fusion-inhibited) to the fusion-active conformation of the murine leukemia virus glycoprotein.

Authors:  Dimitri Lavillette; Alessia Ruggieri; Bertrand Boson; Marielle Maurice; François-Loïc Cosset
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

10.  Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis.

Authors:  M J Kadan; S Sturm; W F Anderson; M A Eglitis
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more
  7 in total

1.  Feline leukemia virus T entry is dependent on both expression levels and specific interactions between cofactor and receptor.

Authors:  Heather H Cheng; Maria M Anderson; Julie Overbaugh
Journal:  Virology       Date:  2006-10-13       Impact factor: 3.616

2.  An equine infectious anemia virus variant superinfects cells through novel receptor interactions.

Authors:  Melinda A Brindley; Baoshan Zhang; Ronald C Montelaro; Wendy Maury
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

3.  Second site mutation in the virus envelope expands the host range of a cytopathic variant of Moloney murine leukemia virus.

Authors:  John Ferrarone; Ryan C Knoper; Randolph Li; Christine A Kozak
Journal:  Virology       Date:  2012-07-24       Impact factor: 3.616

4.  Unique N-linked glycosylation of CasBrE Env influences its stability, processing, and viral infectivity but not its neurotoxicity.

Authors:  Krystal M Renszel; Russell S Traister; William P Lynch
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

5.  TR1.3 viral pathogenesis and syncytium formation are linked to Env-Gag cooperation.

Authors:  Samuel L Murphy; Glen N Gaulton
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

6.  A mutant retroviral receptor restricts virus superinfection interference and productive infection.

Authors:  Meihong Liu; Maribeth V Eiden
Journal:  Retrovirology       Date:  2012-06-12       Impact factor: 4.602

7.  Naturally Occurring Polymorphisms of the Mouse Gammaretrovirus Receptors CAT-1 and XPR1 Alter Virus Tropism and Pathogenicity.

Authors:  Christine A Kozak
Journal:  Adv Virol       Date:  2011-10-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.